image
Veracyte, Inc. VCYT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 35.94
-2.97 %
$ 2.79 B
Market Cap
-276.46
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 21.76% -103.51% -108.84%
Annual Report FY 10-K 2022-12-31 35.09% 51.62% 49.84%
Annual Report FY 10-K 2021-12-31 86.85% -110.79% -131.44%
Annual Report FY 10-K 2020-12-31 -2.40% -117.51% -133.95%
Annual Report FY 10-K 2019-12-31 30.82% 28.34% 31.96%
Annual Report FY 10-K 2018-12-31 27.87% 25.82% 16.22%
Annual Report FY 10-K 2017-12-31 10.55% 1.13% 7.86%
Annual Report FY 10-K 2016-12-31 31.48% 6.96% 13.93%
Annual Report FY 10-K 2015-12-31 29.62% -14.74% -15.38%
Annual Report FY 10-K 2014-12-31 74.51% -14.83% -25.17%
Annual Report FY 10-K 2013-12-31 88.20% -37.17% -22.42%
Annual Report FY 10-K 2012-12-31 339.62% -29.10% -23.99%
Annual Report FY 10-K 2011-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2024-09-30 28.58% 151.17% 137.86%
Quarterly Report Q1 8-K 2024-06-30 26.69% 168.25% 158.45%
Quarterly Report Q4 8-K 2024-03-31 17.50% 67.21% 59.74%
Quarterly Report Q3 8-K 2023-12-31 22.29% -636.03% 73.73%
Quarterly Report Q2 8-K 2023-09-30 19.20% -239.54% -227.88%
Quarterly Report Q1 8-K 2023-06-30 23.96% 11.85% 24.99%
Quarterly Report Q4 8-K 2023-03-31 21.60% 60.69% 26.87%
Quarterly Report Q3 8-K 2022-12-31 19.25% 63.49% 56.05%
Quarterly Report Q2 8-K 2022-09-30 25.21% 38.26% 41.97%
Quarterly Report Q1 8-K 2022-06-30 32.23% -5.47% -43.60%
Quarterly Report Q4 8-K 2022-03-31 84.68% 65.46% 68.39%
Quarterly Report Q3 8-K 2021-12-31 94.97% -30.88% -52.79%
Quarterly Report Q2 8-K 2021-09-30 93.98% -242.60% -310.26%
Quarterly Report Q1 8-K 2021-06-30 166.16% 18.02% 32.37%
Quarterly Report Q4 8-K 2021-03-31 17.93% -257.36% -272.25%
Quarterly Report Q3 8-K 2020-12-31 16.17% -7.86% 1.52%
Quarterly Report Q2 8-K 2020-09-30 0.48% -464.93% -130.63%
Quarterly Report Q1 8-K 2020-06-30 -31.30% -342.06% -256.48%
Quarterly Report Q4 8-K 2020-03-31 5.39% -511.16% -490.23%
Quarterly Report Q3 8-K 2019-12-31 15.46% -140.19% -168.14%
Quarterly Report Q2 8-K 2019-09-30 31.99% 83.67% 59.04%
Quarterly Report Q1 8-K 2019-06-30 32.46% 60.08% 47.61%
Quarterly Report Q4 8-K 2019-03-31 47.34% 79.11% 76.92%
Quarterly Report Q3 8-K 2018-12-31 31.40% 63.21% 49.42%
Quarterly Report Q2 8-K 2018-09-30 33.95% 36.60% 32.41%
Quarterly Report Q1 8-K 2018-06-30 23.61% 14.39% 10.47%
Quarterly Report Q4 8-K 2018-03-31 21.96% -11.68% -19.13%
Quarterly Report Q3 8-K 2017-12-31 7.33% -91.66% -64.60%
Quarterly Report Q2 8-K 2017-09-30 -5.83% -25.05% -30.33%
Quarterly Report Q1 8-K 2017-06-30 25.42% 35.09% 37.02%
Quarterly Report Q4 8-K 2017-03-31 21.27% 18.44% 22.91%
Quarterly Report Q3 8-K 2016-12-31 30.02% 45.05% 53.82%
Quarterly Report Q2 8-K 2016-09-30 50.81% 36.98% 45.03%
Quarterly Report Q1 8-K 2016-06-30 23.24% -23.06% -15.65%
Quarterly Report Q4 8-K 2016-03-31 20.79% -32.39% -29.10%
Quarterly Report Q3 8-K 2015-12-31 15.11% 1.58% 1.34%
Quarterly Report Q2 8-K 2015-09-30 25.38% -13.20% -13.79%
Quarterly Report Q1 8-K 2015-06-30 37.24% -37.28% -38.30%
Quarterly Report Q4 8-K 2015-03-31 50.05% -14.02% -14.87%
Quarterly Report Q3 8-K 2014-12-31 78.40% -38.19% -39.86%
Quarterly Report Q2 8-K 2014-09-30 75.87% -25.37% -28.03%
Quarterly Report Q1 8-K 2014-06-30 71.21% -2.54% -21.12%
Quarterly Report Q4 8-K 2014-03-31 70.53% 3.21% -11.57%
Quarterly Report Q3 8-K 2013-12-31 53.42% -21.81% -12.63%
Quarterly Report Q2 8-K 2013-09-30 73.51% -27.64% -23.53%
Quarterly Report Q1 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2012-09-30 0.00% 0.00% 0.00%